Development of High Throughput Quantitative PCR Assays for RSV
$193,000Y01FY2011AINIH
National Institute Of Allergy And Infectious Diseases
Investigators
Abstract
The contract supports the development of high throughput quantitative PCR assays to detect neutralizing antibody to human respiratory syncytial viruses (subtypes A and B).
View original record on NIH RePORTER →